Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

(2011) Cornelis JH van de Velde et al.   LANCET

Personalized estimates of breast cancer risk in clinical practice and public health

(2011) Mitchell H. Gail   STATISTICS IN MEDICINE

Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial

(2010) R. Eastell et al.   ANNALS OF ONCOLOGY

Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study

(2010) Robert E. Coleman et al.   BREAST CANCER RESEARCH AND TREATMENT

Prevalence of Tamoxifen Use for Breast Cancer Chemoprevention Among U.S. Women

(2010) E. A. Waters et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Long-term Follow-up in Cancer Prevention Trials (It Ain't Over 'Til It's Over)

(2010) J. Cuzick   Cancer Prevention Research

Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis

(2010) Mary E. Ropka et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

(2009) Mitch Dowsett et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating 2-Hydroxy- and 16 -Hydroxy Estrone Levels and Risk of Breast Cancer among Postmenopausal Women

(2008) A. H. Eliassen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

(2008) Richard Eastell et al.   JOURNAL OF CLINICAL ONCOLOGY